BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yu G, Chen X, Chen S, Ye W, Hou K, Liang M. Arsenic trioxide reduces chemo-resistance to 5-fluorouracil and cisplatin in HBx-HepG2 cells via complex mechanisms. Cancer Cell Int 2015;15:116. [PMID: 26692822 DOI: 10.1186/s12935-015-0269-y] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Duan W, Wang H, Fan Q, Chen L, Huang H, Ran H. Cystatin F involvement in adenosine A2A receptor-mediated neuroinflammation in BV2 microglial cells. Sci Rep 2018;8:6820. [PMID: 29717153 DOI: 10.1038/s41598-018-25031-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
2 Jiang X, Chen C, Gu S, Zhang Z. Regulation of ABCG2 by nuclear factor kappa B affects the sensitivity of human lung adenocarcinoma A549 cells to arsenic trioxide. Environ Toxicol Pharmacol 2018;57:141-50. [PMID: 29274627 DOI: 10.1016/j.etap.2017.12.011] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
3 Devarajan N, Manjunathan R, Ganesan SK. Tumor hypoxia: The major culprit behind cisplatin resistance in cancer patients. Crit Rev Oncol Hematol 2021;162:103327. [PMID: 33862250 DOI: 10.1016/j.critrevonc.2021.103327] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Shen J, Wang J, Du J, Wang L, Zhou X, Chang X, Li Z, Zhai X, Zuo D, Wu Y. A novel ALK inhibitor ZYY inhibits Karpas299 cell growth in vitro and in a mouse xenograft model and induces protective autophagy. Toxicology and Applied Pharmacology 2019;383:114781. [DOI: 10.1016/j.taap.2019.114781] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
5 Zuo D, Jiang X, Han M, Shen J, Lang B, Guan Q, Bai Z, Han C, Li Z, Zhang W, Wu Y. Methyl 5-[(1H-indol-3-yl)selanyl]-1H-benzoimidazol-2-ylcarbamate (M-24), a novel tubulin inhibitor, causes G2/M arrest and cell apoptosis by disrupting tubulin polymerization in human cervical and breast cancer cells. Toxicology in Vitro 2017;42:139-49. [DOI: 10.1016/j.tiv.2017.04.019] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
6 Ning K, Ning W, Ning X, Wang X, Zhou F. Effect of As2O3 on colorectal CSCs stained with ALDH1 in primary cell culture in vitro. Oncol Lett 2018;16:4008-12. [PMID: 30128021 DOI: 10.3892/ol.2018.9110] [Reference Citation Analysis]
7 Wen Y, Zhao RQ, Zhang YK, Gupta P, Fu LX, Tang AZ, Liu BM, Chen ZS, Yang DH, Liang G. Effect of Y6, an epigallocatechin gallate derivative, on reversing doxorubicin drug resistance in human hepatocellular carcinoma cells. Oncotarget 2017;8:29760-70. [PMID: 28423656 DOI: 10.18632/oncotarget.15964] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
8 Liang HW, Yang X, Wen DY, Gao L, Zhang XY, Ye ZH, Luo J, Li ZY, He Y, Pang YY, Chen G. Utility of miR‑133a‑3p as a diagnostic indicator for hepatocellular carcinoma: An investigation combined with GEO, TCGA, meta‑analysis and bioinformatics. Mol Med Rep 2018;17:1469-84. [PMID: 29138825 DOI: 10.3892/mmr.2017.8040] [Cited by in Crossref: 6] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
9 Zhou H, Fu LX, Li L, Chen YY, Zhu HQ, Zhou JL, Lv MX, Gan RZ, Zhang XX, Liang G. The epigallocatechin gallate derivative Y6 reduces the cardiotoxicity and enhances the efficacy of daunorubicin against human hepatocellular carcinoma by inhibiting carbonyl reductase 1 expression. J Ethnopharmacol 2020;261:113118. [PMID: 32621953 DOI: 10.1016/j.jep.2020.113118] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Ibrahim AM, Nady S, Shafaa MW, Khalil MM. Radiation and chemotherapy variable response induced by tumor cell hypoxia: impact of radiation dose, anticancer drug, and type of cancer. Radiat Environ Biophys 2022. [PMID: 35396948 DOI: 10.1007/s00411-022-00974-6] [Reference Citation Analysis]
11 Wang J, Dong Z, Sheng Z, Cai Y. Hypoxia-induced PVT1 promotes lung cancer chemoresistance to cisplatin by autophagy via PVT1/miR-140-3p/ATG5 axis. Cell Death Discov 2022;8:104. [PMID: 35256612 DOI: 10.1038/s41420-022-00886-w] [Reference Citation Analysis]
12 Marin JJG, Cives-Losada C, Asensio M, Lozano E, Briz O, Macias RIR. Mechanisms of Anticancer Drug Resistance in Hepatoblastoma. Cancers (Basel) 2019;11:E407. [PMID: 30909445 DOI: 10.3390/cancers11030407] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
13 Chen X, Huang Y, Chen H, Chen Z, Chen J, Wang H, Li D, Su Z. Augmented EPR effect post IRFA to enhance the therapeutic efficacy of arsenic loaded ZIF-8 nanoparticles on residual HCC progression. J Nanobiotechnology 2022;20:34. [PMID: 35033089 DOI: 10.1186/s12951-021-01161-3] [Reference Citation Analysis]
14 Chen Y, Li H, Chen D, Jiang X, Wang W, Li D, Shan H. Hypoxic Hepatocellular Carcinoma Cells Acquire Arsenic Trioxide Resistance by Upregulating HIF-1α Expression. Dig Dis Sci 2021. [PMID: 34383201 DOI: 10.1007/s10620-021-07202-z] [Reference Citation Analysis]
15 Marin JJ, Briz O, Herraez E, Lozano E, Asensio M, Di Giacomo S, Romero MR, Osorio-padilla LM, Santos-llamas AI, Serrano MA, Armengol C, Efferth T, Macias RI. Molecular bases of the poor response of liver cancer to chemotherapy. Clinics and Research in Hepatology and Gastroenterology 2018;42:182-92. [DOI: 10.1016/j.clinre.2017.12.006] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 7.8] [Reference Citation Analysis]
16 Wu Q, Chen X, Wang P, Wu Q, Qi X, Han X, Chen L, Meng X, Xu K. Delivery of Arsenic Trioxide by Multifunction Nanoparticles To Improve the Treatment of Hepatocellular Carcinoma. ACS Appl Mater Interfaces 2020;12:8016-29. [PMID: 31997633 DOI: 10.1021/acsami.9b22802] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]